Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

ClinicalTrials.gov ID: NCT00391872

Public ClinicalTrials.gov record NCT00391872. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 6:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of Ticagrelor Compared With Clopidogrel for Prevention of Vascular Events in Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO- a Study of PLATelet Inhibition and Patient Outcomes]

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Ticagrelor is a new, reversible binding, anti-platelet medication. Anti-platelet medications work to prevent the formation of blood clots. Ticagrelor is being developed as a treatment for patients with acute coronary syndrome (ACS). ACS is a term that is used to describe both heart attacks in progress or the imminent threat of a heart attack. ACS is usually caused by the formation of a blood clot in an artery that partially or totally blocks the blood supply to a portion of the heart muscle. Ticagrelor will be compared with clopidogrel to determine which drug, when either is used in conjunction with aspirin, is better at reducing deaths from vascular causes, future heart attacks and/or strokes in patients with ACS.

Study identification

NCT ID
NCT00391872
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
18,624 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2006 (Type not available)
Primary completion
Mar 2009 (Actual)
Completion
Mar 2009 (Actual)
Last update posted
Mar 13, 2012

2006 – 2009

United States locations

U.S. sites
139
U.S. states
40
U.S. cities
139
Facility City State ZIP Site status
Research Site Birmingham Alabama — —
Research Site Huntsville Alabama — —
Research Site Mobile Alabama — —
Research Site Tucson Arizona — —
Research Site Bakersfield California — —
Research Site Beverly Hills California — —
Research Site Burbank California — —
Research Site Healdsburg California — —
Research Site Los Angeles California — —
Research Site Roseville California — —
Research Site Sacramento California — —
Research Site San Diego California — —
Research Site Torrance California — —
Research Site Fort Collins Colorado — —
Research Site Danbury Connecticut — —
Research Site Hartford Connecticut — —
Research Site Newark Delaware — —
Research Site Washington D.C. District of Columbia — —
Research Site Atlantis Florida — —
Research Site Daytona Beach Florida — —
Research Site Fort Lauderdale Florida — —
Research Site Hollywood Florida — —
Research Site Jacksonville Florida — —
Research Site Jupiter Florida — —
Research Site Melbourne Florida — —
Research Site Miami Beach Florida — —
Research Site Ocala Florida — —
Research Site Orlando Florida — —
Research Site Ormond Beach Florida — —
Research Site Pensacola Florida — —
Research Site Sarasota Florida — —
Research Site St. Petersburg Florida — —
Research Site Chicago Illinois — —
Research Site Park Ridge Illinois — —
Research Site Rock Island Illinois — —
Research Site Rockford Illinois — —
Research Site Indianapolis Indiana — —
Research Site Muncie Indiana — —
Research Site Valparaiso Indiana — —
Research Site Iowa City Iowa — —
Research Site West Des Moines Iowa — —
Research Site Kansas City Kansas — —
Research Site Olathe Kansas — —
Research Site Ashland Kentucky — —
Research Site Louisville Kentucky — —
Research Site Shreveport Louisiana — —
Research Site Auburn Maine — —
Research Site Bangor Maine — —
Research Site Baltimore Maryland — —
Research Site Bethesda Maryland — —
Research Site Salisbury Maryland — —
Research Site Boston Massachusetts — —
Research Site Springfield Massachusetts — —
Research Site Ann Arbor Michigan — —
Research Site Kalamazoo Michigan — —
Research Site Lansing Michigan — —
Research Site Laper Michigan — —
Research Site Pontiac Michigan — —
Research Site Royal Oak Michigan — —
Research Site Saginaw Michigan — —
Research Site Troy Michigan — —
Research Site Ypsilanti Michigan — —
Research Site Duluth Minnesota — —
Research Site Minneapolis Minnesota — —
Research Site Saint Paul Minnesota — —
Research Site Tupelo Mississippi — —
Research Site Columbia Missouri — —
Research Site Joplin Missouri — —
Research Site Kansas City Missouri — —
Research Site St Louis Missouri — —
Research Site Lincoln Nebraska — —
Research Site Omaha Nebraska — —
Research Site Papillion Nebraska — —
Research Site Newark New Jersey — —
Research Site Oakland New Jersey — —
Research Site Paterson New Jersey — —
Research Site Albuquerque New Mexico — —
Research Site Brooklyn New York — —
Research Site Buffalo New York — —
Research Site Johnson City New York — —
Research Site Kingston New York — —
Research Site New Hartford New York — —
Research Site New York New York — —
Research Site Rochester New York — —
Research Site Syracuse New York — —
Research Site Williamsville New York — —
Research Site Chapel Hill North Carolina — —
Research Site Charlotte North Carolina — —
Research Site Greensboro North Carolina — —
Research Site High Point North Carolina — —
Research Site Raleigh North Carolina — —
Research Site Winston-Salem North Carolina — —
Research Site Cleveland Ohio — —
Research Site Columbus Ohio — —
Research Site Kettering Ohio — —
Research Site Zanesville Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Tulsa Oklahoma — —
Research Site Bend Oregon — —
Research Site Camp Hill Pennsylvania — —
Research Site Danville Pennsylvania — —
Research Site Doylestown Pennsylvania — —
Research Site Harrisburg Pennsylvania — —
Research Site Lancaster Pennsylvania — —
Research Site Langhorne Pennsylvania — —
Research Site Philadelphia Pennsylvania — —
Research Site Pittsburgh Pennsylvania — —
Research Site Sayre Pennsylvania — —
Research Site Sellersville Pennsylvania — —
Research Site Wormleysburg Pennsylvania — —
Research Site York Pennsylvania — —
Research Site Providence Rhode Island — —
Research Site Wakefield Rhode Island — —
Research Site Anderson South Carolina — —
Research Site Charleston South Carolina — —
Research Site Columbia South Carolina — —
Research Site Greenville South Carolina — —
Research Site Rapid City South Dakota — —
Research Site Jackson Tennessee — —
Research Site Knoxville Tennessee — —
Research Site Memphis Tennessee — —
Research Site Amarillo Texas — —
Research Site Austin Texas — —
Research Site Dallas Texas — —
Research Site Houston Texas — —
Research Site Lubbock Texas — —
Research Site San Antonio Texas — —
Research Site San Marcos Texas — —
Research Site Tyler Texas — —
Research Site Victoria Texas — —
Research Site Burlington Vermont — —
Research Site Falls Church Virginia — —
Research Site Fredericksburg Virginia — —
Research Site Norfolk Virginia — —
Research Site Winchester Virginia — —
Research Site Everett Washington — —
Research Site Tacoma Washington — —
Research Site Morgantown West Virginia — —
Research Site Green Bay Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 533 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00391872, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2012 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00391872 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →